US FDA Commissioner praises TrumpRx plan as “major step” towards making prescription medications more affordable for Americans. The plan, which includes Pfizer’s agreement to offer discounts on certain medications, aims to address the country’s rising healthcare costs and make medication more accessible to those who struggle to afford them. However, critics argue that the program may not provide significant savings for most Americans and may not pressure pharmaceutical companies enough to lower prices.
Source: https://www.cbsnews.com/news/fda-head-marty-makary-praises-trumprx-prescription-medications-affordability-pfizer